# US 2016/0256608 A1 · Scaffold-free self-organized 3d synthetic tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256608 A1
- Document ID: US20160256608A1
- Status: Published application
- Kind: A1
- Application number: 15/166,059
- Filed: 2016-05-26
- Published: 2016-09-08
- Earliest claimed: 2003-08-01
- Assignees: Two Cells Co., Ltd.
- Applicants: Two Cells, Co., Ltd.
- Inventors: Norimasa Nakamura; Hideki Yoshikawa; Wataru Ando
- Web page: https://patentgrep.com/patent/US20160256608A1

## CPC

- A61L 27/3612: {Cartilage, synovial fluid}
- A61L 27/24: Collagen
- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/3852: {Cartilage, e.g. meniscus}
- A61L 27/3895: {using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 19/00: Drugs for skeletal disorders
- C07K 14/47: from mammals
- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- C12N 5/0655: {Chondrocytes; Cartilage}
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- C12N 2500/25: Insulin-transferrin; Insulin-transferrin-selenium
- C12N 2500/38: Vitamins
- C12N 2501/135: Platelet-derived growth factor [PDGF]
- C12N 2501/15: Transforming growth factor beta (TGF-β)
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2501/20: Cytokines; Chemokines
- C12N 2501/33: Insulin
- C12N 2501/39: Steroid hormones
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2502/1311: Osteocytes, osteoblasts, odontoblasts
- C12N 2506/1384: from adipose-derived stem cells [ADSC], from adipose stromal stem cells
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention can be used for actual implantation surgery without a scaffold. The present invention provides a synthetic tissue or complex which can be produced by culture and has a high level of differentiation ability. The present invention also provides a therapy and medicament for repairing and/or regenerating tissue using replacement and covering. By culturing cells under specific culture conditions such that medium contains an extracellular matrix synthesis promoting agent, the cells are organized and are easily detached from a culture dish. The present invention was achieved by finding such a phenomenon. In addition, the self contraction of the tissue can be regulated by culturing the tissue in a suspended manner. Therefore, it is possible to regulate the three-dimensional shape of the tissue. The present invention also provides a method for producing an implantable synthetic tissue which does not require a plurality of monolayer cell sheets assembled to form a three-dimensionally structured synthetic tissue. The present invention is characterized by richness in adhesion molecules, nonnecessity of additional fixation at an implantation site, and good biological integration.

## Claims

### Claim 1

A tissue complex comprising an implantable synthetic autograft or allograft tissue and another synthetic tissue for implantation in a recipient,
wherein the implantable synthetic autograft or allograft tissue is substantially made of (i) cells that are autologous or allogeneic relative to the recipient and which thereby constitute the synthetic autograft or allograft tissue, said cells being selected from the group consisting of myoblasts, mesenchymal stem cells, adipocytes, synovial cells and bone marrow cells; and (ii) an extracellular matrix (ECM) derived from the cells constituting the synthetic autograft or allograft tissue, said extracellular matrix comprising fibronectin, collagen I, collagen III, and vitronectin,
wherein the synthetic autograft or allograft tissue is free of scaffolds and comprises multiple layers of said cells, and
wherein the implantable synthetic autograft or allograft tissue has integration ability with its surroundings when implanted and has sufficient strength to provide self-supporting ability.

### Claim 2 (depends on 1)

The tissue complex of claim 1, wherein the fibronectin, collagen I, collagen III, and vitronectin are evenly distributed in the synthetic autograft or allograft tissue.

### Claim 3 (depends on 1)

The tissue complex of claim 1, wherein the fibronectin, collagen I, collagen III, and vitronectin three-dimensionally wrap the cells.

### Claim 4 (depends on 1)

The tissue complex of claim 1, wherein the extracellular matrix is integrated throughout the tissue.

### Claim 5 (depends on 1)

The tissue complex of claim 1, wherein the implantable synthetic autograft or allograft tissue comprises 10 or more layers of said cells.

### Claim 6 (depends on 1)

The tissue complex of claim 1, wherein the implantable synthetic autograft or allograft tissue has a thickness of at least about 50 μm and is dimensioned so as to fit an injured site in a tissue or organ.
